Osteoporosis in inflammatory joint diseases (Q37765505)

22 August 2017

1 reference

title

Osteoporosis in inflammatory joint diseases (English)

1 reference

22 August 2017

0 references

0 references

C Roux

1

1 reference

PubMed ID

20552328

22 August 2017

language of work or name

English

0 references

publication date

15 June 2010

1 reference

Osteoporosis International

22 August 2017

1 reference

22 August 2017

22

1 reference

22 August 2017

2

1 reference

22 August 2017

421-433

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-010-1319-x

22 August 2017

0 references

cites work

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Risk of vertebral fracture in women with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Fall incidence and fall risk factors in people with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Correlates of falls and fear of falling among adults with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone mineral density of the hand in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Hand bone densitometry in rheumatoid arthritis, a five year longitudinal study: an outcome measure and a prognostic marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital x ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Digital X-ray radiogrammetry combined with semiautomated analysis of joint space widths as a new diagnostic approach in rheumatoid arthritis: a cross-sectional and longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Detailed analyses of periarticular osteoporosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Osteoclasts are essential for TNF-alpha-mediated joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Interaction between synovial inflammatory tissue and bone marrow in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Interleukin-1 is essential for systemic inflammatory bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Appendicular and vertebral bone mass in ankylosing spondylitis. A comparison of plain radiographs with single- and dual-photon absorptiometry and with quantitative computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone density, ultrasound measurements and body composition in early ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Intracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Distinct topography of erosion and new bone formation in achilles tendon enthesitis: Implications for understanding the link between inflammation and bone formation in spondylarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Pathophysiological role of endothelin in ectopic ossification of human spinal ligaments induced by mechanical stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Treg cells suppress osteoclast formation: a new link between the immune system and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

CTLA-4 directly inhibits osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-010-1319-X

Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis

21 January 2018

1 reference

12 December 2020

High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis

1 reference

12 December 2020

Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis

1 reference

12 December 2020

Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register

1 reference

12 December 2020

Muscle quality, architecture, and activation in cachectic patients with rheumatoid arthritis

1 reference

12 December 2020

Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study

1 reference

12 December 2020

High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study

1 reference

12 December 2020

Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity

1 reference

12 December 2020

Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

1 reference

12 December 2020

The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction

1 reference

12 December 2020

Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.

1 reference

12 December 2020

Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women.

1 reference

12 December 2020

A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis

1 reference

12 December 2020

Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high resolution computed tomography

1 reference

12 December 2020

Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis

1 reference

12 December 2020

Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis

1 reference

12 December 2020

Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment

1 reference

12 December 2020

Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements

1 reference

12 December 2020

Clinical vertebral fractures in patients with ankylosing spondylitis

1 reference

12 December 2020

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

12 December 2020

Vertebral fractures in patients with rheumatoid arthritis treated with corticosteroids

1 reference

12 December 2020

Osteoporosis in early ankylosing spondylitis: a primary pathological event?

1 reference

12 December 2020

TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis

1 reference

12 December 2020

Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study

1 reference

12 December 2020

The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density

1 reference

12 December 2020

RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis

1 reference

12 December 2020

Tumor necrosis factor α and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis

1 reference

12 December 2020

Fractures after rheumatoid arthritis. A population-based study

1 reference

12 December 2020

Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register

1 reference

12 December 2020

The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women

1 reference

12 December 2020

Determinants of axial bone loss in rheumatoid arthritis

1 reference

12 December 2020

Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes

1 reference

12 December 2020

High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis

1 reference

12 December 2020

Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis

1 reference

12 December 2020

Is bone turnover a determinant of bone mass in rheumatoid arthritis?

1 reference

12 December 2020

RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies

1 reference

12 December 2020

Fracture risk in patients with ankylosing spondylitis: a population based study.

1 reference

12 December 2020

Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study

1 reference

12 December 2020

Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study.

1 reference

12 December 2020

Osteoporosis, body composition, and bone turnover in ankylosing spondylitis

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020

The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio

1 reference

12 December 2020

Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation

1 reference

12 December 2020

Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density

1 reference

12 December 2020

Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women

1 reference

12 December 2020

Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls

1 reference

12 December 2020

Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study

1 reference

12 December 2020

10.1007/S00198-010-1319-X

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20552328